NCT00672958View on ClinicalTrials.gov

Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

600

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Major Depressive Disorder

Interventions

DRUG

Vortioxetine

Encapsulated immediate-release tablets.

DRUG

Placebo

Vortioxetine placebo-matching capsules.

Trial Locations (33)

Unknown

Birmingham

Cerritos

Encino

Fresno

San Diego

Farmington

Jacksonville

North Miami

Tampa

Hoffman Estate

Lafayette

Valparaiso

Shreveport

Saint Paul

Florissant

Saint Charles

Las Vegas

Rochester

Dayton

Toledo

Tulsa

Philadelphia

Lincoln

North Charleston

Nashville

Houston

Lake Jackson

Wichita Falls

Brown Deer

Middleton

Hull

Mexico City

San Luis Potosí City

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

H. Lundbeck A/S

INDUSTRY

lead

Takeda

INDUSTRY

NCT00672958 - Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder | Biotech Hunter | Biotech Hunter